These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18823551)

  • 21. Familial focal segmental glomerulosclerosis (FSGS) in a Nigerian family and exclusion of mutations in NPHS2,WT1 and APOL1.
    Anochie IC; Eke FU; Okpere AN
    West Afr J Med; 2012; 31(4):273-6. PubMed ID: 23468032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [NPHS2 Mutation analysis study in children with steroid-resistant nephrotic syndrome].
    Azocar M; Vega Á; Farfán M; Cano F
    Rev Chil Pediatr; 2016; 87(1):31-6. PubMed ID: 26455708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Report of novel genetic variation in NPHS2 gene associated with idiopathic nephrotic syndrome in South Indian children.
    Dhandapani MC; Venkatesan V; Rengaswamy NB; Gowrishankar K; Ekambaram S; Sengutavan P; Perumal V
    Clin Exp Nephrol; 2017 Feb; 21(1):127-133. PubMed ID: 26820844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NPHS2 mutations in adult patients with primary focal segmental glomerulosclerosis.
    Monteiro EJ; Pereira AC; Pereira AB; Krieger JE; Mastroianni-Kirsztajn G
    J Nephrol; 2006; 19(3):366-71. PubMed ID: 16874699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis.
    Caridi G; Bertelli R; Carrea A; Di Duca M; Catarsi P; Artero M; Carraro M; Zennaro C; Candiano G; Musante L; Seri M; Ginevri F; Perfumo F; Ghiggeri GM
    J Am Soc Nephrol; 2001 Dec; 12(12):2742-2746. PubMed ID: 11729243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rare functional variants of podocin (NPHS2) promoter in patients with nephrotic syndrome.
    Oleggini R; Bertelli R; Di Donato A; Di Duca M; Caridi G; Sanna-Cherchi S; Scolari F; Murer L; Allegri L; Coppo R; Emma F; Camussi G; Perfumo F; Ghiggeri GM
    Gene Expr; 2006; 13(1):59-66. PubMed ID: 16572591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cis and trans regulatory elements in NPHS2 promoter: implications in proteinuria and progression of renal diseases.
    Di Duca M; Oleggini R; Sanna-Cherchi S; Pasquali L; Di Donato A; Parodi S; Bertelli R; Caridi G; Frasca G; Cerullo G; Amoroso A; Schena FP; Scolari F; Ghiggeri GM;
    Kidney Int; 2006 Oct; 70(7):1332-41. PubMed ID: 16900088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NPHS2 gene, nephrotic syndrome and focal segmental glomerulosclerosis: a HuGE review.
    Franceschini N; North KE; Kopp JB; McKenzie L; Winkler C
    Genet Med; 2006 Feb; 8(2):63-75. PubMed ID: 16481888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. mRNA sequencing of a novel NPHS2 intronic mutation in a child with focal and segmental glomerulosclerosis.
    Benetti E; Caridi G; Centi S; Vella MD; Ghiggeri GM; Artifoni L; Murer L
    Saudi J Kidney Dis Transpl; 2014 Jul; 25(4):854-7. PubMed ID: 24969201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic basis of nephrotic syndrome--review.
    Obeidová H; Merta M; Reiterová J; Maixnerová D; Stekrová J; Rysavá R; Tesar V
    Prague Med Rep; 2006; 107(1):5-16. PubMed ID: 16752799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NPHS2 gene polymorphism aggravates renal damage caused by focal segmental glomerulosclerosis with COL4A3 mutation.
    Sun L; Zhang X; Wang Z
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33305316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence.
    Weber S; Gribouval O; Esquivel EL; Morinière V; Tête MJ; Legendre C; Niaudet P; Antignac C
    Kidney Int; 2004 Aug; 66(2):571-9. PubMed ID: 15253708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence that NPHS2-R229Q predisposes to proteinuria and renal failure in familial hematuria.
    Voskarides K; Arsali M; Athanasiou Y; Elia A; Pierides A; Deltas C
    Pediatr Nephrol; 2012 Apr; 27(4):675-9. PubMed ID: 22228437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-Transplant Recurrence of Focal Segmental Glomerulosclerosis in a Child With Heterozygous Mutations in NPHS1 and NPHS2.
    Battelino N; Arnol M; Kandus A; Ponikvar R; Novljan G
    Ther Apher Dial; 2016 Jun; 20(3):312-7. PubMed ID: 27312921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Super-Resolution Imaging of the Filtration Barrier Suggests a Role for Podocin R229Q in Genetic Predisposition to Glomerular Disease.
    Butt L; Unnersjö-Jess D; Höhne M; Hahnfeldt R; Reilly D; Rinschen MM; Plagmann I; Diefenhardt P; Brähler S; Brinkkötter PT; Brismar H; Blom H; Schermer B; Benzing T
    J Am Soc Nephrol; 2022 Jan; 33(1):138-154. PubMed ID: 34853150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for NPHS2 mutations may help predict FSGS recurrence after transplantation.
    Jungraithmayr TC; Hofer K; Cochat P; Chernin G; Cortina G; Fargue S; Grimm P; Knueppel T; Kowarsch A; Neuhaus T; Pagel P; Pfeiffer KP; Schäfer F; Schönermarck U; Seeman T; Toenshoff B; Weber S; Winn MP; Zschocke J; Zimmerhackl LB
    J Am Soc Nephrol; 2011 Mar; 22(3):579-85. PubMed ID: 21355056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association of podocin R229Q polymorphism with increased albuminuria or reduced estimated GFR in a large population-based sample of US adults.
    Köttgen A; Hsu CC; Coresh J; Shuldiner AR; Berthier-Schaad Y; Gambhir TR; Smith MW; Boerwinkle E; Kao WH
    Am J Kidney Dis; 2008 Nov; 52(5):868-75. PubMed ID: 18499321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations in podocyte genes are a rare cause of primary FSGS associated with ESRD in adult patients.
    Büscher AK; Konrad M; Nagel M; Witzke O; Kribben A; Hoyer PF; Weber S
    Clin Nephrol; 2012 Jul; 78(1):47-53. PubMed ID: 22732337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Broadening the spectrum of diseases related to podocin mutations.
    Caridi G; Bertelli R; Di Duca M; Dagnino M; Emma F; Onetti Muda A; Scolari F; Miglietti N; Mazzucco G; Murer L; Carrea A; Massella L; Rizzoni G; Perfumo F; Ghiggeri GM
    J Am Soc Nephrol; 2003 May; 14(5):1278-86. PubMed ID: 12707396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nephrotic Syndrome With Mutations in NPHS2: The Role of R229Q and Implications for Genetic Counseling.
    Rood IM; Deegens JKJ; Lugtenberg D; Bongers EMHF; Wetzels JFM
    Am J Kidney Dis; 2019 Mar; 73(3):400-403. PubMed ID: 30241959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.